Manejo multidisciplinario y avances terapéuticos en la esclerosis lateral amiotrófica

  • Matamala J
  • Moreno-Roco J
  • Acosta I
  • et al.
N/ACitations
Citations of this article
60Readers
Mendeley users who have this article in their library.

Abstract

Multidisciplinary care and therapeutic advances in amyotrophic lateral sclerosis Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that mainly affects the motor system, resulting in progressive weakness and muscle wasting. Despite the tremendous advances in physiopathological and clinical characterization, we do not have a curative treatment yet. The progressive and fatal course of ALS makes its management particularly complex and challenging given the diversity of symptoms presenting during the disease progression. The main goal in the treatment of ALS patients is to minimize morbidity and maximize the quality of life. Currently, a series of therapeutic interventions improve the quality of life and prolong survival, including multidisciplinary care, respiratory management, and disease-modifying therapy. Within the supportive interventions, weight maintenance through nutritional and metabolic support is critical. In addition, the management of neuropsychiatric manifestations and preservation of communicative capacity before speech loss are also crucial. Lastly, early palliative care intervention is essential to optimize symptomatic management. Anticipatory guidelines to face the inevitable patient deterioration should be devised. This article updates the main therapeutic strategies used in these patients, including evolving clinical trials with promising novel therapies. (Rev Med Chile 2022; 150: 1633-1646) L a esclerosis lateral amiotrófica (ELA) es una enfermedad neurodegenerativa que afecta a las motoneuronas superiores (MNS) e inferiores (MNI), generando progresivamente de-bilidad y atrofia muscular. Clínicamente, presenta una gran variabilidad en su forma de presentación y progresión, con una sobrevida media de 3 a 5 años 1. La clínica y anatomía patológica de la ELA co-menzó a ser descrita en forma bastante clara desde el siglo XIX. Histológicamente, se caracteriza por la pérdida de las MNS en la capa V de la corteza

Cite

CITATION STYLE

APA

Matamala, J. M., Moreno-Roco, J., Acosta, I., Hughes, R., Lillo, P., Casar, J. C., & Earle, N. (2022). Manejo multidisciplinario y avances terapéuticos en la esclerosis lateral amiotrófica. Revista Médica de Chile, 150(12), 1633–1646. https://doi.org/10.4067/s0034-98872022001201633

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free